Sinovac Biotech Co., Ltd: Foot-and-Mouth Disease trials
The registry lists 12 Foot-and-Mouth Disease studies with Sinovac Biotech Co., Ltd as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 3 3Phase 4 5No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in IndonesiaNot yet recruitingNCT06251219
- A Serosurvey Study of Hand, Foot, and Mouth Disease in IndonesiaCompletedNCT05637229
- Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in ShanghaiStatus unknownNCT05166044
- Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization VaccinesCompletedNCT04111432Phase 4
- Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 MonthsCompletedNCT03909074Phase 3
- Efficacy Trial of a Commercial EV71 VaccineCompletedNCT03903926Phase 4
- Immunogenicity and Safety of Two Different Commercial EV71 VaccinesCompletedNCT03873740Phase 4
- Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT03281174
- Phase IV Clinical Trial, Immunogenicity and Safety of EV71 VaccineCompletedNCT03278132Phase 4
- Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI VaccinesCompletedNCT03274102Phase 4
- Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01636245Phase 3
- An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01507857Phase 3